# Provectus Biopharmaceuticals, Inc.: filings

PVCT · OTC · CIK 315545 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pvct.md) · [Financials](/companies/pvct/financials.md) · [Filings](/companies/pvct/filings.md) · [Insiders](/companies/pvct/insiders.md)

## Reports and events: 385 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 263, 4 258, 10-Q 53, CORRESP 24, DEF 14A 23, UPLOAD 21, 10-K 18, DEFA14A 18, 424B3 17, D 15, PRE 14A 14, EFFECT 13, 3 10, 424B5 9, S-1/A 7, SC TO-I/A 6, POS AM 5, SC 13D/A 5, 10-K/A 4, ARS 4, S-3 4, SC 13D 4, SC 13G 4, SC 13G/A 4, PRER14A 3, 25-NSE 2, 8-A12B 2, 8-K/A 2, AW 2, CERTNYS 2, CT ORDER 2, D/A 2, DFAN14A 2, FWP 2, NT 10-K 2, S-1 2, S-3/A 2, S-4 2, SCHEDULE 13D/A 2, SC TO-I 2, 10-Q/A 1, 3/A 1, 424B4 1, 4/A 1, 8-A12G 1, S-4/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 13:21 ET | [10-Q](/filings/0001493152-26-037671.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037671 |
| 2026-07-22 | 15:04 ET | [SCHEDULE 13D/A](/filings/0001493152-26-034217.md) | Ownership report, active investor, amended | 0001493152-26-034217 |
| 2026-07-01 | 19:37 ET | [8-K](/filings/0001493152-26-031379.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-031379 |
| 2026-06-22 | 09:00 ET | [8-K](/filings/0001493152-26-029512.md) | 5.07 Shareholder vote results | 0001493152-26-029512 |
| 2026-06-18 | 14:59 ET | [8-K](/filings/0001493152-26-029280.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029280 |
| 2026-05-14 | 13:52 ET | [10-Q](/filings/0001493152-26-022950.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022950 |
| 2026-04-30 | 11:06 ET | [DEF 14A](/filings/0001493152-26-019805.md) | Proxy statement, period 2026-04-30 | 0001493152-26-019805 |
| 2026-04-21 | 21:19 ET | [8-K](/filings/0001493152-26-018160.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018160 |
| 2026-03-26 | 17:38 ET | [10-K](/filings/0001493152-26-012726.md) | Annual report, period 2025-12-31 | 0001493152-26-012726 |
| 2026-02-02 | 15:30 ET | [8-K](/filings/0001493152-26-004730.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-004730 |
| 2025-12-08 | 09:53 ET | [SCHEDULE 13D](/filings/0001493152-25-026550.md) | Ownership report, active investor | 0001493152-25-026550 |
| 2025-12-01 | 21:52 ET | [SCHEDULE 13D/A](/filings/0001493152-25-025639.md) | Ownership report, active investor, amended | 0001493152-25-025639 |
| 2025-11-13 | 14:36 ET | [10-Q](/filings/0001493152-25-022229.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022229 |
| 2025-08-14 | 13:56 ET | [10-Q](/filings/0001641172-25-023864.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023864 |
| 2025-06-20 | 06:15 ET | [8-K](/filings/0001641172-25-015695.md) | 5.07 Shareholder vote results | 0001641172-25-015695 |
| 2025-06-18 | 08:43 ET | [8-K](/filings/0001641172-25-015520.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015520 |
| 2025-05-16 | 14:24 ET | [10-K/A](/filings/0001641172-25-011210.md) | Annual report, amended, period 2024-12-31 | 0001641172-25-011210 |
| 2025-05-14 | 16:14 ET | [10-Q](/filings/0001641172-25-010273.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010273 |
| 2025-05-01 | 18:43 ET | [DEF 14A](/filings/0001641172-25-007928.md) | Proxy statement, period 2025-04-30 | 0001641172-25-007928 |
| 2025-04-16 | 13:35 ET | [8-K](/filings/0001641172-25-004995.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-004995 |
| 2025-03-28 | 17:38 ET | [10-K](/filings/0001641172-25-000993.md) | Annual report, period 2024-12-31 | 0001641172-25-000993 |
| 2025-01-22 | 13:31 ET | [8-K](/filings/0001493152-25-003193.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-003193 |
| 2024-12-26 | 09:30 ET | [8-K](/filings/0001493152-24-052029.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-052029 |
| 2024-12-11 | 09:00 ET | [8-K](/filings/0001493152-24-049571.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-049571 |
| 2024-12-06 | 19:45 ET | [SC 13D/A](/filings/0001493152-24-049162.md) | Ownership report, active investor, amended | 0001493152-24-049162 |
| 2024-12-05 | 19:57 ET | [8-K](/filings/0001493152-24-048734.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-048734 |
| 2024-11-14 | 08:00 ET | [8-K](/filings/0001493152-24-045353.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-045353 |
| 2024-11-12 | 15:34 ET | [10-Q](/filings/0001493152-24-044720.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044720 |
| 2024-08-19 | 15:06 ET | [8-K](/filings/0001493152-24-033053.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-033053 |
| 2024-08-13 | 13:21 ET | [10-Q](/filings/0001493152-24-031524.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031524 |
| 2024-07-17 | 15:50 ET | [8-K](/filings/0001493152-24-028157.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-028157 |
| 2024-07-03 | 19:29 ET | [SC 13D](/filings/0001493152-24-026262.md) | Ownership report, active investor | 0001493152-24-026262 |
| 2024-06-25 | 15:41 ET | [8-K](/filings/0001493152-24-025080.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-025080 |
| 2024-06-21 | 13:56 ET | [8-K](/filings/0001493152-24-024661.md) | 5.07 Shareholder vote results | 0001493152-24-024661 |
| 2024-06-20 | 09:30 ET | [8-K](/filings/0001493152-24-024449.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-024449 |
| 2024-05-14 | 14:43 ET | [10-Q](/filings/0001493152-24-019184.md) | Quarterly report, period 2024-03-31 | 0001493152-24-019184 |
| 2024-05-06 | 13:56 ET | [DEF 14A](/filings/0001493152-24-017882.md) | Proxy statement, period 2024-05-06 | 0001493152-24-017882 |
| 2024-04-29 | 13:10 ET | [10-K/A](/filings/0001493152-24-016883.md) | Annual report, amended, period 2023-12-31 | 0001493152-24-016883 |
| 2024-04-16 | 16:58 ET | [8-K](/filings/0001493152-24-014848.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-014848 |
| 2024-03-28 | 14:35 ET | [10-K](/filings/0001493152-24-011699.md) | Annual report, period 2023-12-31 | 0001493152-24-011699 |
| 2024-03-27 | 12:10 ET | [8-K](/filings/0001493152-24-011443.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-011443 |
| 2024-03-26 | 16:48 ET | [8-K](/filings/0001493152-24-011327.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-011327 |
| 2024-02-22 | 09:30 ET | [8-K](/filings/0001493152-24-007506.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-007506 |
| 2024-02-15 | 08:05 ET | [8-K](/filings/0001493152-24-006815.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-006815 |
| 2023-11-14 | 11:35 ET | [10-Q](/filings/0001493152-23-040856.md) | Quarterly report, period 2023-09-30 | 0001493152-23-040856 |
| 2023-08-14 | 13:40 ET | [10-Q](/filings/0001493152-23-028230.md) | Quarterly report, period 2023-06-30 | 0001493152-23-028230 |
| 2023-06-22 | 14:33 ET | [8-K](/filings/0001493152-23-022116.md) | 5.07 Shareholder vote results | 0001493152-23-022116 |
| 2023-06-21 | 09:50 ET | [8-K](/filings/0001493152-23-021927.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-021927 |
| 2023-05-11 | 14:41 ET | [10-Q](/filings/0001493152-23-016356.md) | Quarterly report, period 2023-03-31 | 0001493152-23-016356 |
| 2023-05-01 | 13:58 ET | [DEF 14A](/filings/0001493152-23-014910.md) | Proxy statement, period 2023-05-01 | 0001493152-23-014910 |

Page 1 of 8. [Older](/companies/pvct/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 11:33 ET. No prices; not investment advice.